Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: J Immunol. 2022 Jan 7;208(3):732–744. doi: 10.4049/jimmunol.2100184

Figure 5: IL-33-induced activation does not modulate activation marker expression on ST2-deficient bystander eosinophils.

Figure 5:

BMDE were generated from five biologically distinct ST2−/−/WT (50/50) mixed bone marrow chimeras. Cells were stimulated on culture d14 with anti-Siglec-F or isotype antibody and optional IL-33 for 24 hrs and were analyzed for expression of indicated surface markers by flow cytometry. Bars show mean fluorescence ± SEM pregated on living cells and the distinct genotype portion and normalized to the mean of all unstimulated controls of the respective genotype (n=5 of 2 independent experiments; Two-way ANOVA with Bonferroni posttests; **p <0.01, ***p <0.001).